Objective: To reassess the role of plasmapheresis in the treatment of neurologic disorders.
Methods: We evaluated the available evidence based on a structured literature review for …

Background Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a
chronic progressive or relapsing and remitting disease that usually causes weakness and …

Importance Familial amyloid polyneuropathy, a lethal genetic disease caused by
aggregation of variant transthyretin, induces progressive peripheral nerve deficits and …

Abstract The American Society for Apheresis (ASFA) Apheresis Applications Committee is
charged with a review and categorization of indications for therapeutic apheresis. Beginning …

Objective: To determine the validity and reliability of the total neuropathy score (TNS) in
normal subjects and in subjects with diabetic polyneuropathy. Background: Clinical research …

Chronic inflammatory demyelinating polyradiculoneuropathy is a paralytic syndrome,
causing considerable disability and even death. In controlled clinical trials, plasma …

A number of presentations of chronic demyelinating polyneuropathy have been identified,
each distinguished by its phenotypic pattern. In addition to classic chronic inflammatory …

Article abstract-We report the clinical and EMG details of 67 consecutive patients with strictly
defined chronic inflammatory demyelinating polyneuropathy (CIDP) during a 4-year period …

Background Serum monoclonal anti‐myelin‐associated glycoprotein (anti‐MAG) antibodies
may be pathogenic in some people with immunoglobulin M (IgM) paraprotein and …

PURPOSE: To review the clinical features, complications, and treatment of Waldenström's
macroglobulinemia, a low-grade lymphoproliferative disorder that produces monoclonal …